MARC Record from marc_columbia

LEADER: 05239cam a2200577 a 4500
001 6321290
005 20221122022616.0
008 070316t20072007nyuaf b 001 0 eng
016 7 $a101310681$2DNLM
016 7 $a980843480$2GyFmDB
020 $a9781402054655 (hb)
020 $a1402054653 (hb)
020 $a9781402054662 (e-book)
020 $a1402054661 (e-book)
029 0 $aNLM$b101310681
029 1 $aOHX$bhar060114178
029 1 $aYDXCP$b2481553
029 1 $aNLGGC$b30117721X
035 $a(OCoLC)ocm86075161
035 $a(OCoLC)86075161
035 $a(NNC)6321290
035 $a6321290
040 $aNLM$cNLM$dOHX$dBAKER$dCUS$dYDXCP$dAGL$dBTCTA$dOrLoB-B
042 $anlmcopyc
050 4 $aQH599
060 00 $aW1$bSU14 v.41 2007
060 10 $aQU 56$bC5573 2007
070 0 $aQH599$b.C572 2007
072 7 $aQH$2lcco
072 7 $aQP$2lcco
245 00 $aChromatin and disease /$cedited by Tapas K. Kundu and Dipak Dasgupta.
260 $aNew York, NY :$bSpringer,$c[2007], ©2007.
300 $axiii, 433 pages, 22 unnumbered pages of plates :$billustrations.
336 $atext$btxt$2rdacontent
337 $aunmediated$bn$2rdamedia
490 1 $aSub-cellular biochemistry,$x0306-0225 ;$vv. 41
504 $aIncludes bibliographical references and index.
505 00 $gPt. I.$tChromatin structure, dynamics and disease -- $g1.$tStructural organization of dynamic chromatin /$rKohji Hizume, Shige H. Yoshimura, Masahiro Kumeta and Kunio Takeyasu -- $g2.$tATP-dependent chromatin remodelling : action and reaction /$rParul Choudhary and Patrick Varga-Weisz -- $g3.$tRegulation of chromatin structure and chromatin-dependent transcription by poly(ADP-ribose) polymerase-1 : possible targets for drug-based therapies /$rDavid A. Wacker, Kristine M. Frizzell, Tong Zhang and W. Lee Kraus -- $g4.$tHistone variant nucleosomes : structure, function and implication in disease /$rMathieu Boulard, Philippe Bouvet, Tapas K. Kundu and Stefan Dimitrov -- $g5.$tHistone variants and complexes involved in their exchange /$rThomas Kusch and Jerry L. Workman -- $g6.$tHistone chaperones in chromatin dynamics : implications in disease manifestation /$rJayasha Shandilya, Shrikanth Gadad, V. Swaminathan and Tapas K. Kundu -- $g7.$tFunctions of the histone chaperone nucleolin in diseases /$rSebastien Storck, Manu Shukla, Stefan Dimitrov and Philippe Bouvet -- $g8.$tChromatin as a target for the DNA-binding anticancer drugs /$rParijat Majumder, Suman K. Pradhan, Pukhrambam Grihanjali Devi, Sudipta Pal and Dipak Dasgupta -- $gPt. II.$tNonhistone proteins, sites for epigenetic marks : link to disease -- $g9.$tReversible acetylation of non histone proteins : role in cellular function and disease /$rKiran Batta, Chandrima Das, Shrikanth Gadad, Jayasha Shandilya and Tapas K. Kundu -- $g10.$tMARs and MARBPs : key modulators of gene regulation and disease manifestation /$rSamit Chattopadhyay and Lakshminarasimhan Pavithra -- $gPt. III.$tEpigenetic modifications of chromatin : implication in disease and therapeutics -- $g11.$tAberrant forms of histone acetyltransferases in human disease /$rOlivier Van Beekum and Eric Kalkhoven -- $g12.$tChromatin acetylation status in the manifestation of neurodegenerative diseases : HDAC inhibitors as therapeutic tools /$rBoutillier Anne-Laurence, Rouaux Caroline, Panteleeva Irina and Loeffler Jean-Philippe -- $g13.$tFunctions of MYST family histone acetyltransferases and their link to disease /$rNikita Avvakumov and Jacques Cote -- $g14.$tRole of histone phosphorylation in chromatin dynamics and its implications for diseases /$rMasaya Oki, Hitoshi Aihara and Takashi Ito -- $g15.$tRegulation and function of H3K9 methylation /$rYoichi Shinkai -- $g16.$tHistone acetylation and methylation : combinatorial players for transcriptional regulation /$rWoojin An -- $g17.$tChromatin-associated regulation of HIV-1 transcription : implications for the development of therapeutic strategies /$rVincent Quivy, Stephane de Walque and Carine Van Lint -- $g18.$tSmall molecule modulators in epigenetics : implications in gene expression and therapeutics /$rV. Swaminathan, B. A. Ashok Reddy, Ruthrotha Selvi B., Sukanya M. S. and Tapas K. Kundu.
650 12 $aChromatin$xpathology.$0https://id.nlm.nih.gov/mesh/D002843Q000473
650 22 $aChromatin$xphysiology.$0https://id.nlm.nih.gov/mesh/D002843Q000502
650 22 $aEpigenesis, Genetic.$0https://id.nlm.nih.gov/mesh/D044127
650 22 $aHistones$xphysiology.$0https://id.nlm.nih.gov/mesh/D006657Q000502
650 22 $aHistones$xtherapeutic use.$0https://id.nlm.nih.gov/mesh/D006657Q000627
650 0 $aChromatin.$0http://id.loc.gov/authorities/subjects/sh85025333
650 0 $aEpigenesis.$0http://id.loc.gov/authorities/subjects/sh85044382
650 0 $aDrug targeting.$0http://id.loc.gov/authorities/subjects/sh88005350
650 0 $aHuman genome.$0http://id.loc.gov/authorities/subjects/sh94002900
700 1 $aKundu, Tapas K.$0http://id.loc.gov/authorities/names/no2007058368
700 1 $aDasgupta, Dipak.$0http://id.loc.gov/authorities/names/no2007071977
830 0 $aSub-cellular biochemistry ;$vv. 41.$0http://id.loc.gov/authorities/names/no97030144
852 00 $boff,bio$hQH573$i.S8 v.41